Your search returned 3 results.

Results
	1.	Low molecular weight heparin tinzaparin antagonizes cisplatin resistance of ovarian cancer cells. [electronic resource] by Pfankuchen, Daniel Bastian Stölting, Daniel Philipp Schlesinger, Martin Royer, Hans-Dieter Bendas, Gerd Producer: 20151127 In: Biochemical pharmacology vol. 97 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Heparin antagonizes cisplatin resistance of A2780 ovarian cancer cells by affecting the Wnt signaling pathway. [electronic resource] by Pfankuchen, Daniel Bastian Baltes, Fabian Batool, Tahira Li, Jin-Ping Schlesinger, Martin Bendas, Gerd Publication details: Oncotarget Sep 2017 In: Oncotarget vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	The Impact of the Low Molecular Weight Heparin Tinzaparin on the Sensitization of Cisplatin-Resistant Ovarian Cancers-Preclinical In Vivo Evaluation in Xenograft Tumor Models. [electronic resource] by Mueller, Thomas Pfankuchen, Daniel Bastian Wantoch von Rekowski, Kathleen Schlesinger, Martin Reipsch, Franziska Bendas, Gerd Producer: 20170818 In: Molecules (Basel, Switzerland) vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search